Aptahem AB (publ) (NGM:APTA)
Sweden · Delayed Price · Currency is SEK 0.7140
+0.0440 (6.57%)
At close: May 20, 2026
Aptahem AB Market Cap
Aptahem AB has a market cap or net worth of 18.52 million as of May 21, 2026. Its market cap has decreased by -5.05% in one year.
Market Cap
18.52M
Enterprise Value
15.55M
Revenue
2.59M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.71
Market Cap Chart
Since April 17, 2015, Aptahem AB's market cap has decreased from 51.10M to 18.52M, a decrease of -63.76%. That is a compound annual growth rate of -8.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 18.52M | -22.89% |
| Dec 30, 2025 | 24.01M | 35.28% |
| Dec 30, 2024 | 17.75M | -4.71% |
| Dec 29, 2023 | 18.63M | -73.52% |
| Dec 30, 2022 | 70.35M | -20.14% |
| Dec 30, 2021 | 88.10M | -5.79% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Spago Nanomedical AB | 91.30M |
| Pila Pharma AB | 84.97M |
| Alzinova AB | 81.35M |
| Modus Therapeutics Holding AB | 58.14M |
| 2cureX AB | 49.60M |
| Fluicell AB | 40.80M |
| Guard Therapeutics International AB | 28.23M |
| Biosergen AB | 22.31M |